| HOME >> BIOLOGY >> TECHNOLOGY |
-- Research and development ("R&D") costs. Non-GAAP R&D costs for the
fourth quarter of 2009 were RMB4.3 million (US$0.6 million), or 5.7% of
net revenue, compared to RMB5.3 million (US$0.8 million), or 8.9% of
net revenue, for the same period in 2008. GAAP R&D costs for the fourth
quarter of 2009 were RMB5.1 million (US$0.7 million), or 6.9% of net
revenue, compared to RMB12.4 million (US$1.8 million), or 20.7% of net
revenue, for the same period in 2008.
-- Sales, marketing and distribution expenses. Non-GAAP sales, marketing
and distribution expenses for the fourth quarter of 2009 were
RMB40.8 million (US$6.0 million), or 55.0% of net revenue, compared to
RMB38.0 million (US$5.6 million), or 63.3% of net revenue, for the same
period in 2008. GAAP sales, marketing and distribution expenses for the
fourth quarter of 2009 were RMB40.9 million (US$6.0 million), or 55.1%
of net revenue, compared to RMB38.3 million (US$5.6 million), or 63.8%
of net revenue, for the same period in 2008.
-- General and administrative expenses. Non-GAAP general and
administrative expenses for the fourth quarter of 2009 were
RMB9.7 million (US$1.4 million), or 13.0% of net revenue, compared to
RMB5.1 million (US$0.8 million),
'/>"/>
| SOURCE 3SBio Inc. Copyright©2010 PR Newswire. All rights reserved |